Pharmaceutical news, Pharma industry, Pharmaceutical manufacturing

Top Headlines

Pharmacy detects ‘high levels’ of new carcinogen in valsartan batches

Valisure detects fourth probable carcinogen in valsartan medication and criticises the US FDA’s daily exposure limits as lacking a ‘rational basis’ and being ‘of significant concern’.

Sandoz joins pilot project to develop 2D matrix alternative

Sandoz has signed up to participate in a FDA pilot project to assess the use of RFID as an alternative data carrier to 2D barcodes.

EU industry loses €16.5bn in sales to counterfeit drugs

A report from the EUIPO demonstrated that a shift in the focus of counterfeited goods to include pharmaceutical products has caused significant loss of sales and employment.

FDA to ‘institutionalize’ compounding regulation to ‘protect consumers’

The US FDA is set to center its drug compounding regulatory program in an office focused on stopping poor quality, unsafe and ineffective drugs reaching patients.